Qu, C., Ping, N., Kong, D., Zhu, Q., Li, J., Zhang, X., Xia, F., Zou, R., He, S., Wu, D., Jin, Z. (2025). Chidamide in combination with brentuximab vedotin for CD30+ peripheral T-cell lymphoma in patients ineligible for chemotherapy: a prospective phase II study. Blood. https://doi.org/10.1182/blood-2025-7167